loader image
Monday, December 22, 2025
73.1 F
McAllen
- Advertisement -

Colorectal Cancer Screening Disparities Found in Hispanic/Latino Communities

New Cleveland Clinic research shows there are disparities when it comes to colorectal cancer screenings for the Hispanic and Latino communities here in the United States.

Translate to Spanish or other 102 languages!

Recent Cleveland Clinic research shows there are some disparities in the Hispanic and Latino communities when it comes to colorectal cancer screenings. Image for illustration purposes
Recent Cleveland Clinic research shows there are some disparities in the Hispanic and Latino communities when it comes to colorectal cancer screenings. Image for illustration purposes
- Advertisement -

CLEVELAND CLINIC – Recent Cleveland Clinic research shows there are some disparities in the Hispanic and Latino communities when it comes to colorectal cancer screenings.

It appears they have lower screening rates.

“Colorectal cancer is one of the leading causes of cancer death among Hispanic or Latino populations, and so it is an extremely important public health problem,” explained Blake Buchalter, PhD, researcher for Cleveland Clinic.

- Advertisement -

Buchalter, who led the research team, said they developed an interactive map to determine which populations had the lowest colorectal cancer screening rates.

They also examined different component groups, such as the Cuban population, Mexican population, and Dominican population.

Buchalter said it’s unclear why exactly there are disparities in colorectal cancer screenings in the Hispanic and Latino communities.

That’s something that needs to be further studied.

- Advertisement -

In the meantime, he hopes the data can be used to help improve rates of colorectal cancer screenings.

“Policy makers, public health practitioners, and the public can actually go online and look at this [interactive map} and sort of see what these relationships look like in different geographic regions of the United States. And then that helps to basically identify these areas where funding or other policies could be targeted,” said Buchalter.

Currently, it’s recommended that adults start getting regular colorectal cancer screenings when they turn 45.

Those with an increased risk or who have a family history may need to get screened sooner.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves Daily Pill to Treat Low Libido in Women After Menopause

On December 15, 2025, the U.S. Food and Drug Administration (FDA) approved the medication Addyi (flibanserin) for the treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women under the age of 65.

Heart Association Highlights 2025’s Major Research Findings

In 2025, cardiovascular investigators worldwide reported findings that could help fill important gaps in preventing and managing conditions including high blood pressure, stroke, heart failure, dangerous blood clots and aortic stenosis.

Uniting Experts to Revolutionize Cancer Treatment

More than 70% of all cancers are impacted by mutations caused by a group of DNA-editing enzymes that drives tumor growth and drug resistance. The apolipoprotein B mRNA-editing enzyme catalytic polypeptide, or APOBEC, family, is a dominant factor in many cancers including bladder, breast, cervical, head and neck and lung.

Early Findings Show Breast Cancer Vaccine Produces Immune Response

Cleveland Clinic released its findings from the first phase of the clinical trial for the preventive breast cancer vaccine. 
- Advertisement -
×